CN106591310B - A kind of Escherichia coli high-strength combination promoter and its application - Google Patents

A kind of Escherichia coli high-strength combination promoter and its application Download PDF

Info

Publication number
CN106591310B
CN106591310B CN201611126585.7A CN201611126585A CN106591310B CN 106591310 B CN106591310 B CN 106591310B CN 201611126585 A CN201611126585 A CN 201611126585A CN 106591310 B CN106591310 B CN 106591310B
Authority
CN
China
Prior art keywords
promoter
intensity
rpst
combination
dna
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN201611126585.7A
Other languages
Chinese (zh)
Other versions
CN106591310A (en
Inventor
周景文
陈坚
周胜虎
堵国成
李华钟
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Jiangnan University
Original Assignee
Jiangnan University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Jiangnan University filed Critical Jiangnan University
Priority to CN201611126585.7A priority Critical patent/CN106591310B/en
Publication of CN106591310A publication Critical patent/CN106591310A/en
Application granted granted Critical
Publication of CN106591310B publication Critical patent/CN106591310B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/24Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
    • C07K14/245Escherichia (G)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/70Vectors or expression systems specially adapted for E. coli
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2800/00Nucleic acids vectors
    • C12N2800/10Plasmid DNA
    • C12N2800/101Plasmid DNA for bacteria
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00Vector systems having a special element relevant for transcription
    • C12N2830/34Vector systems having a special element relevant for transcription being a transcription initiation element

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Biophysics (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

The invention discloses a kind of Escherichia coli high-strength combination promoter and its applications, belong to synthesising biological technical field.The present invention provides high Intensity of Transcription of Endothelial promoter PssrA、PdnaKJ、PgrpE、PalsRBACEIntensity promoter P is translated with heightrpsT.Respectively by PssrA、PdnaKJ、PgrpE、PalsRBACEAnd PrpsT4 kinds of combination promoters with high expression intensity are obtained after fusion.The maximum intensity of the combination promoter is the P of 10mM arabinose inductionBAD1.7 times of promoter.The combination promoter is a kind of safety and efficient gene expression element.

Description

A kind of Escherichia coli high-strength combination promoter and its application
Technical field
The present invention relates to a kind of Escherichia coli high-strength combination promoter and its applications, belong to synthesising biological technical field.
Background technique
As first control element of gene expression, the table of gene downstream is controlled by regulating and controlling the intensity of promoter Become most direct effective means up to level.During metabolic engineering, the strategy such as modularization utilizes different copy numbers Plasmid and IPTG induction promoter successfully multiple gene expression doses of metabolic pathway are finely tuned, greatly increase Purpose product yield is added.
Currently, the most commonly used is a series of inducible promoters in Escherichia coli, however due to inducible promoter Quantity limitation, therefore these promoters are often difficult to and carry out accuracy controlling to each Gene expression intensities.Microorganism A large amount of natural promoter is carried on genome, these promoter intensity multiplicity have applied to the huge of metabolic engineering Big potentiality.However, since the intensity of most of constitutive promoter is unknown, and promoter precise sequence corresponding with intensity is not Know so that directly difficult using constitutive promoter progress gene expression.Furthermore the transcription of most natural promoter is strong The translation intensity disunity in gene is spent, the protein that often promoter with high transcriptional level is translated is not but high, and low The promoter of transcriptional level but possesses higher protein expression level.It often multiple promoters, enhancer and declines on genome Subtract the expression that the elements such as son adjust a gene jointly, therefore the promoter region of different length its function is also not quite similar.Such as What, which finds the constitutive promoter with high Intensity of Transcription of Endothelial and high translation intensity, becomes key.
Summary of the invention
To solve the above-mentioned problems, it present invention firstly provides one group of Escherichia coli constitutive promoter, clearly determines Its Intensity of Transcription of Endothelial and translation intensity, provide its specific DNA sequence dna.The present invention is the inducer during avoiding gene expression Addition provides selection, while can be used for adjusting polygenic expression by way of control bacterial metabolism flow direction.
Shown in the nucleotide sequence of the Escherichia coli constitutive promoter such as NO.6~9 SEQ ID are any.
The present invention also provides a kind of expression vector, have nucleotide sequence as NO.6~9 SEQ ID it is any shown in start Son.The skeleton of the expression vector includes the expression vector of common Escherichia coli.
The present invention provides the recombinant bacterium of application promoter building.
In one embodiment of the invention, the host of the recombinant bacterium includes various existing Bacillus coli expression places It is main.
In one embodiment of the invention, the recombinant bacterium constructed using the promoter is to utilize the starting Son connection target gene, construction recombination plasmid, and express in host.
In traditional genetic engineering research, inducible promoter is frequently used to expression related gene, however due to needing It adds inducer and is difficult to realize simultaneously be finely adjusted multiple Gene expression intensities, inducible promoter is dfficult to apply to more Gene Expression Pathway.Constitutive promoter from genome is often due to its expression intensity is lower is equally difficult to meet to want It asks.The 4 kinds provided by the invention high-strength combination promoters with gradient intensity do not need additional addition inducer, have height Intensity of Transcription of Endothelial and high translation intensity, while it can be used for pair with certain intensity gradient (promoter intensity span is 7.7 times) Multi-gene expression approach is finely adjusted.
Specific embodiment
Materials and methods
E. coli jm109 is used for plasmid construction, and e. coli k12 MG1655 is strong for expressing protein determination promoter Degree.
Embodiment 1
Escherichia coli transcript profile data are analyzed, using e. coli k12 MG1655 genome as template, expand promoter PssrA、PdnaKJ、PgrpE、PalsRBACEAnd PrpsT.For the intensity for measuring this 5 promoters, P is merged in a manner of fusion DNA vaccinessrA、 PdnaKJ、PgrpE、PalsRBACE、PrpsTWith reporter gene EGFP.
To measure and constructing high-strength combination promoter, by promoter P in a manner of fusion DNA vaccinessrA、PdnaKJ、PgrpEWith PalsRBACETranscriptional control regions (- 10th area and -35th area) and promoter PrpsTThe region 5'-UTR fusion, thus building obtain 4 Kind combination promoter PssrA-rpsT、PdnaKJ-rpsT、PgrpE-rpsTAnd PalsRBACE-rpsT.Then will combination promoter and EGFP gene with The mode of fusion DNA vaccine is merged for measuring combination promoter intensity.Pcr amplification reaction is by high-fidelity DNA polymerase PrimeSTAR HS (premix) (TaKaRa) amplification.Amplimer is shown in Table 1.
1 the primer sequence of table
Artificial sequence
Fusion DNA vaccine product is connect after BamHI/SacI double digestion with the pCDFDuet-1 plasmid of same double digestion, In chemical conversion e. coli k12 MG1655.Correct bacterial strain is sequenced for subsequent promoter strength detection.
1, Intensity of Transcription of Endothelial
Recombinant bacterium is cultivated under the conditions of 220rpm 37 DEG C in LB culture medium or MOPS, culture to after stationary phase (11h) in 4000rpm, 4 DEG C thalline were collected by centrifugation, extracts total mRNA of thallus, and real-time quantitative PCR detection is carried out after reverse transcription, measures EGFP MRNA abundance intracellular, testing result is shown, using promoter PssrA、PdnaKJ、PgrpE、PalsRBACEAnd PrpsT, mRNA abundance It is the P of 10mM arabinose induction respectivelyBAD46.3,25.6,8.3,6.4 and 0.0047 times of promoter.
2, intensity is translated
In order to measure constitutive promoter PssrA、PdnaKJ、PgrpE、PalsRBACEAnd PrpsTTranslation intensity, using EGFP as table Up to gene, stationary phase detection detection EGFP intracellular intracellular is horizontal in Escherichia coli MG1655.Recombinant bacterium is cultivated in LB or MOPS It 37 DEG C in base, is cultivated under the conditions of 220rpm, in 4000rpm after culture to stationary phase (11h), 4 DEG C thalline were collected by centrifugation, utilizes PBS (pH=7.4) buffer solution for cleaning cell 2 times, to remove dead thallus, thallus secretion and culture medium precipitate component to reduce Fluorescence detection background.By the thallus after cleaning as in 96 hole fluorescent plates in Multifunction fluorescent microplate reader fluorescence intensity and bacterium Body OD600, testing conditions are 488nm excitation, 520nm transmitting.It is fluorescence intensity and OD that promoter, which translates intensity,600Ratio.
Fluorescence microplate reader testing result shows, promoter PssrA、PdnaKJ、PgrpE、PalsRBACEAnd PrpsTTranslation intensity point Not Wei 10mM arabinose induction PBAD0,0.16,0.06,0.016 and 0.26 times of promoter.
Compare promoter PssrA、PdnaKJ、PgrpE、PalsRBACEAnd PrpsTTranscription and translation intensity discovery to EGFP, starting Sub- PssrA、PdnaKJ、PgrpEAnd PalsRBACEIntensity of Transcription of Endothelial with higher, and it is relatively low to translate intensity.Promoter PrpsTHave Lower Intensity of Transcription of Endothelial, and it is higher to translate intensity.Analyze reason, it may be possible to due to promoter PssrA、PdnaKJ、PgrpEAnd PalsRBACE The promoter P containing strong transcriptional control regions (- 10th area and -35th area)rpsTThen there is the stronger region 5'-UTR.Therefore it combines Both sides' advantage is possible to building and obtains high-intensitive combination promoter
3, the translation intensity of promoter is combined
In order to measure the combination promoter P after promoter is engineeredssrA-rpsT、PdnaKJ-rpsT、PgrpE-rpsTWith PalsRBACE-rpsTExpression intensity, using EGFP as expressing gene, stationary phase detects detection born of the same parents intracellular in Escherichia coli MG1655 Interior EGFP is horizontal.The translation intensity of fluorescence microplate reader testing result display combination promoter is respectively what 10mM arabinose induced PBAD1.70,1.37,0.80 and 0.22 times of promoter.It follows that the four kinds of combination promoters obtained by promoter engineering PssrA-rpsT、PdnaKJ-rpsT、PgrpE-rpsTAnd PalsRBACE-rpsTIt has been provided simultaneously with PssrA、PdnaKJ、PgrpEAnd PalsRBACEThe height of promoter Transcriptional efficiency and PrpsTThe high translation efficiency of promoter.
4, the universality of promoter expressing gene is combined
Since four kinds of combination promoters all have the identical region 5'-UTR, in order to detect this combination tandem promoter Sub- 5'-mRNA can only choose promoter P for the ability to express of different genesssrA-rpsTOther reporter genes are expressed, and Its expression intensity is measured, so that it is determined that deriving from PrpsT5'-mRNA influence that different genes are expressed.
P is used respectivelyssrA-rpsTIt combines promoter and merges table with red fluorescent protein (RFP) and beta galactosidase (LacZ) It reaches, then measuring it and translating intensity is respectively PBAD1.4 times of promoter and 1.7 times.It is demonstrated experimentally that being directed to different purpose bases Cause combines promoter expression intensity equally with higher.
5, the negative sense result of combination promoter building
It should be noted that former due to the influence of mRNA secondary structure, and to promoter can be destroyed when starting sub-portfolio transformation Some functional areas, therefore the transcript regions of the high-intensitive promoter of combination and the region 5'-UTR may not be able to access forward junction Fruit.
Utilize another high translation intensity constitutive promoter PinfC-rplTThe region 5'-UTR and PssrA、PdnaKJ、PgrpE、 PalsRBACETranscript regions combination construct a series of combination promoter, PssrA-infC-rplT、PdnaKJ-infC-rplT、PgrpE-infC-rplT And PalsRBACE-infC-rplT.However, being measured discovery to the translation intensity of these four combination promoters: it translates intensity difference For PinfC-rplT0.94,0.58,0.51,0.21 times.These types combination promoter intensity is declined.
Although the present invention has been described by way of example and in terms of the preferred embodiments, it is not intended to limit the invention, any to be familiar with this skill The people of art can do various change and modification, therefore protection model of the invention without departing from the spirit and scope of the present invention Enclosing subject to the definition of the claims.
SEQUENCE LISTING
<110>Southern Yangtze University
<120>a kind of Escherichia coli high-strength combination promoter and its application
<160> 23
<170> PatentIn version 3.3
<210> 1
<211> 146
<212> DNA
<213>e. coli k12 MG1655
<400> 1
attggctatc acatccgaca caaatgttgc catcccattg cttaatcgaa taaaaatcag 60
gctacatggg tgctaaatct ttaacgataa cgccattgag gctggtcatg gcgctcataa 120
atctggtata cttaccttta cacatt 146
<210> 2
<211> 175
<212> DNA
<213>e. coli k12 MG1655
<400> 2
gcacaaaaaa tttttgcatc tcccccttga tgacgtggtt tacgacccca tttagtagtc 60
aaccgcagtg agtgagtctg caaaaaaatg aaattgggca gttgaaacca gacgtttcgc 120
ccctattaca gactcacaac cacatgatga ccgaatatat agtggagacg tttag 175
<210> 3
<211> 99
<212> DNA
<213>e. coli k12 MG1655
<400> 3
gattgatgac aatgtgagtg cttcccttga aaccctgaaa ctgatcccca taataagcga 60
agttagcgag atgaatgcga aaaaaacgcg gagaaattc 99
<210> 4
<211> 206
<212> DNA
<213>e. coli k12 MG1655
<400> 4
agcaacatct atcatctaaa aaaccagaaa aacaaataac atcatgtttt taaactaatt 60
aaatgaaata aaattttaag ccactcgcca ttgttcacaa taaaataaac tttataaatt 120
ttattttttt gtgaagtcgc cagcatcttt tctgttcttg ctgtggtgat atagtggcgt 180
cttcaattca aggacaagag aacgtg 206
<210> 5
<211> 192
<212> DNA
<213>e. coli k12 MG1655
<400> 5
tgctgcaatt tttatcgcgg aaaagctgta ttcacacccc gcaagctggt agaatcctgc 60
gccatcacta cgtaacgagt gccggcacat taacggcgct tatttgcaca aatccattga 120
caaaagaagg ctaaaagggc atattcctcg gcctttgaat tgtccatata gaacacattt 180
gggagttgga cc 192
<210> 6
<211> 271
<212> DNA
<213>artificial sequence
<400> 6
attggctatc acatccgaca caaatgttgc catcccattg cttaatcgaa taaaaatcag 60
gctacatggg tgctaaatct ttaacgataa cgccattgag gctggtcatg gcgctcataa 120
atctggtata cttaccttta ccatcactac gtaacgagtg ccggcacatt aacggcgctt 180
atttgcacaa atccattgac aaaagaaggc taaaagggca tattcctcgg cctttgaatt 240
gtccatatag aacacatttg ggagttggac c 271
<210> 7
<211> 288
<212> DNA
<213>artificial sequence
<400> 7
gcacaaaaaa tttttgcatc tcccccttga tgacgtggtt tacgacccca tttagtagtc 60
aaccgcagtg agtgagtctg caaaaaaatg aaattgggca gttgaaacca gacgtttcgc 120
ccctattaca gactcacaac cacatgatga ccgaatacca tcactacgta acgagtgccg 180
gcacattaac ggcgcttatt tgcacaaatc cattgacaaa agaaggctaa aagggcatat 240
tcctcggcct ttgaattgtc catatagaac acatttggga gttggacc 288
<210> 8
<211> 192
<212> DNA
<213>artificial sequence
<400> 8
gattgatgac aatgtgagtg cttcccttga aaccctgaaa ctgatcccca taataagcga 60
accatcacta cgtaacgagt gccggcacat taacggcgct tatttgcaca aatccattga 120
caaaagaagg ctaaaagggc atattcctcg gcctttgaat tgtccatata gaacacattt 180
gggagttgga cc 192
<210> 9
<211> 197
<212> DNA
<213>artificial sequence
<400> 9
agcaacatct atcatctaaa aaaccagaaa aacaaataac atcatgtttt taaactaatt 60
aaatgaccat cactacgtaa cgagtgccgg cacattaacg gcgcttattt gcacaaatcc 120
attgacaaaa gaaggctaaa agggcatatt cctcggcctt tgaattgtcc atatagaaca 180
catttgggag ttggacc 197
<210> 10
<211> 40
<212> DNA
<213>artificial sequence
<400> 10
ctagctagct agggatccat tggctatcac atccgacaca 40
<210> 11
<211> 56
<212> DNA
<213>artificial sequence
<400> 11
tgaaaagttc ttctccctta cccataatgt gtaaaggtaa gtataccaga tttatg 56
<210> 12
<211> 51
<212> DNA
<213>artificial sequence
<400> 12
ggcactcgtt acgtagtgat ggtaaaggta agtataccag atttatgagc g 51
<210> 13
<211> 41
<212> DNA
<213>artificial sequence
<400> 13
ctagctagct agggatccgc acaaaaaatt tttgcatctc c 41
<210> 14
<211> 52
<212> DNA
<213>artificial sequence
<400> 14
tgaaaagttc ttctccctta cccatctaaa cgtctccact atatattcgg tc 52
<210> 15
<211> 45
<212> DNA
<213>artificial sequence
<400> 15
ggcactcgtt acgtagtgat ggtattcggt catcatgtgg ttgtg 45
<210> 16
<211> 34
<212> DNA
<213>artificial sequence
<400> 16
tagggatccg attgatgaca atgtgagtgc ttcc 34
<210> 17
<211> 47
<212> DNA
<213>artificial sequence
<400> 17
tgaaaagttc ttctccctta cccatgaatt tctccgcgtt tttttcg 47
<210> 18
<211> 37
<212> DNA
<213>artificial sequence
<400> 18
atagggatcc agcaacatct atcatctaaa aaaccag 37
<210> 19
<211> 49
<212> DNA
<213>artificial sequence
<400> 19
tgaaaagttc ttctccctta cccatcacgt tctcttgtcc ttgaattga 49
<210> 20
<211> 29
<212> DNA
<213>artificial sequence
<400> 20
tagggatccg cgggcattcg tgttaaagc 29
<210> 21
<211> 52
<212> DNA
<213>artificial sequence
<400> 21
tgaaaagttc ttctccctta cccatacctt attcctccaa ttgtttaaga ct 52
<210> 22
<211> 34
<212> DNA
<213>artificial sequence
<400> 22
cgcggtaccg agctcggccg caaattaaag cctt 34
<210> 23
<211> 24
<212> DNA
<213>artificial sequence
<400> 23
atgggtaagg gagaagaact tttc 24

Claims (7)

1. a kind of element for controlling gene expression, which is characterized in that shown in its nucleotide sequence such as NO.6~9 SEQ ID are any.
2. the element of the control gene expression of one group of gradient intensity, which is characterized in that including nucleotide sequence such as SEQ ID NO.6 At least two in promoter shown in~9.
3. a kind of expression vector, which is characterized in that the nucleotide sequence of its gene expression control elements such as NO.6~9 SEQ ID Shown in any.
4. a kind of expression vector according to claim 3, which is characterized in that the skeleton of the expression vector includes existing The expression vector of Escherichia coli.
5. a kind of expression system, which is characterized in that containing nucleotide sequence as shown at least one in NO.6~9 SEQ ID Control the element of gene expression.
6. a kind of element for controlling gene expression described in claim 1 is in the application of Metabolism of E. coli engineering field.
7. the element of the control gene expression of one group of gradient intensity as claimed in claim 2 is in Metabolism of E. coli engineering field Using.
CN201611126585.7A 2016-12-09 2016-12-09 A kind of Escherichia coli high-strength combination promoter and its application Active CN106591310B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201611126585.7A CN106591310B (en) 2016-12-09 2016-12-09 A kind of Escherichia coli high-strength combination promoter and its application

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201611126585.7A CN106591310B (en) 2016-12-09 2016-12-09 A kind of Escherichia coli high-strength combination promoter and its application

Publications (2)

Publication Number Publication Date
CN106591310A CN106591310A (en) 2017-04-26
CN106591310B true CN106591310B (en) 2019-10-25

Family

ID=58597868

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201611126585.7A Active CN106591310B (en) 2016-12-09 2016-12-09 A kind of Escherichia coli high-strength combination promoter and its application

Country Status (1)

Country Link
CN (1) CN106591310B (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN116875594B (en) * 2023-04-26 2024-01-30 江南大学 Construction and application of pediococcus acidilactici high-strength combined promoter

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
Obtaining a Panel of Cascade Promoter-5′-UTR Complexes in Escherichia coli.;Zhou Shenghu ,等;《ACS Synth. Biol》;20170302;第6卷;第1065-1075页 *
一种带增强子的原核高效表达载体的构建及初步应用;罗文新 等;《生物工程学报》;20000930;第16卷(第5期);第578-581页 *
人工合成启动子文库研究进展;余君涵, 等;《微生物学报》;20160120;第43卷(第1期);第198-204页 *
短短小芽孢杆菌-大肠杆菌穿梭分泌表达载体的构建;彭清忠 等;《生物工程学报》;20020731;第18卷(第4期);第438-441页 *

Also Published As

Publication number Publication date
CN106591310A (en) 2017-04-26

Similar Documents

Publication Publication Date Title
Popp et al. The Bacillus BioBrick Box 2.0: expanding the genetic toolbox for the standardized work with Bacillus subtilis
US8501454B2 (en) Homologous recombination-based DNA cloning compositions
Ogasawara et al. PdhR (pyruvate dehydrogenase complex regulator) controls the respiratory electron transport system in Escherichia coli
Berkner et al. Inducible and constitutive promoters for genetic systems in Sulfolobus acidocaldarius
Balasubramanian et al. Rapid recombinant protein production from piggyBac transposon-mediated stable CHO cell pools
CN101541968B (en) Dnase expression recombinant host cells
Zhao et al. Exploration of a natural reservoir of flocculating genes from various Saccharomyces cerevisiae strains and improved ethanol fermentation using stable genetically engineered flocculating yeast strains
CN106754920B (en) A kind of Escherichia coli high intensity Gene expression and its application
CN107344962B (en) Repressor protein, regulatory element group, gene expression regulatory system and construction method thereof
He et al. Engineering industrial Saccharomyces cerevisiae strain with the FLO1-derivative gene isolated from the flocculating yeast SPSC01 for constitutive flocculation and fuel ethanol production
US11697818B2 (en) Pyruvate-responsive biosensor, and construction method and use thereof
CN113939588A (en) Temperature sensitive RNA guided endonucleases
CN112501193A (en) Nicotinic acid and nicotinamide biosensing system
CN106591310B (en) A kind of Escherichia coli high-strength combination promoter and its application
Phan et al. A generic protocol for intracellular expression of recombinant proteins in Bacillus subtilis
CN103626852A (en) AraC mutant protein and application thereof
Lewin et al. Viral promoters can initiate expression of toxin genes introduced into Escherichia coli
Wu et al. The primary and secondary translocase activities within E. coli RecBC helicase are tightly coupled to ATP hydrolysis by the RecB motor
Bezy et al. Functional characterization of a cyanobacterial OmpR/PhoB class transcription factor binding site controlling light color responses
CN116947980B (en) Temperature control expression system and construction method thereof
Yumerefendi et al. Library-based methods for identification of soluble expression constructs
WO2020124831A1 (en) Method for constructing high-efficiency bacillus subtilis promoters
Huo et al. Identifying amino acid overproducers using rare-codon-rich markers
Oshima et al. Functional identification of ygiP as a positive regulator of the ttdA-ttdB-ygjE operon
US20190185865A1 (en) Use of prokaryotic transcriptional activators as metabolite biosensors in eukaryotic cells

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant